SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
This Quarter Return
+11.61%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$249M
AUM Growth
-$11.8M
(-4.5%)
Cap. Flow
-$29.7M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
71.1%
Holding
28
New
5
Increased
5
Reduced
10
Closed
7
Top Buys
| 1 |
Vaxcyte
PCVX
|
$12.6M |
| 2 |
Disc Medicine
IRON
|
$11.8M |
| 3 |
ABVX
Abivax
ABVX
|
$8.91M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$8.23M |
| 5 |
Amicus Therapeutics
FOLD
|
$8.23M |
Top Sells
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
$17.7M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$16.2M |
| 3 |
Cytokinetics
CYTK
|
$12.9M |
| 4 |
Biogen
BIIB
|
$8.4M |
| 5 |
Astria Therapeutics
ATXS
|
$7.61M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Jasper Therapeutics
JSPR
$42.4M
| – | – |
-138,622
| Closed | -$1.09M |
|
|
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-750,250
| Closed | -$17.7M |
|
|
AMAM
28
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – |
-52,781
| Closed | -$752K |
|